CT-2103 vs Gemcitabine or Vinorelbine for the Treatment of PS [performance status] = 2 Patients With Chemotherapy Naive Advanced Non-Small Cell Lung Cancer (NSCLC): A Phase III Study

Trial Profile

CT-2103 vs Gemcitabine or Vinorelbine for the Treatment of PS [performance status] = 2 Patients With Chemotherapy Naive Advanced Non-Small Cell Lung Cancer (NSCLC): A Phase III Study

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 25 Jul 2014

At a glance

  • Drugs Gemcitabine; Paclitaxel poliglumex; Vinorelbine
  • Indications Non-small cell lung cancer
  • Focus Registrational; Therapeutic Use
  • Acronyms STELLAR-4
  • Sponsors CTI BioPharma
  • Most Recent Events

    • 25 Jul 2014 Last checked against ClinicalTrials.gov record.
    • 07 Jul 2008 Results reported in the Journal of Thoracic Oncology in July 2008, according to a Cell Therapeutics media release.
    • 01 Jul 2008 Primary endpoint results published in the Journal of Thoracic Oncology in July 2008
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top